BZ | Analyzing Short Selling Trends for Krystal Biotech (NASDAQ:KRYS)
Market Overview on Krystal Biotech
In recent trading sessions, the short percent of float for Krystal Biotech, identified by its NASDAQ symbol KRYS, has experienced a notable decline of 4.6% since the last report.
Current Short Selling Data
According to recent metrics, Krystal Biotech currently has 3.50 million shares sold short, constituting approximately 16.18% of all regular shares available for trading.
Implications for Investors
This downward trend in short selling could indicate a shift in market sentiment towards Krystal Biotech, sparking interest among potential investors looking to capitalize on changing conditions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.